Access to cancer drugs in Australia is coming to a head after a bitter tit for tat over a pharma push to fast-track oncology treatment. The industry is calling for a more flexible and fast-tracked approach to approving new cancer drugs, claiming the current system is outdated. Australia ranks 18th out of 20 comparable OECD … Continued
New studies which show that patients in some countries can wait years longer than those in others to access potentially life-saving cancer drugs demonstrate the need for better collaboration between doctors and health authorities globally, say researchers. A comparison of approval times for 41 cancer drugs in Canada, the US and the European Union found … Continued
Sign up to receive updates from GAfPA
Setting the Record Straight on COVID-19 Vaccines
January 21, 2021
Pandemic Challenges Shake Europeans with Rare Diseases
January 14, 2021